OPTIPARK trial opicapone in clinical practice

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=GJKJ8uCrhOU

Georg Ebersbach, MD, Movement Disorders Clinic, Beelitz‐Heilstätten, Germany, discusses the OPTIPARK trial (NCT02847442), a prospective, open-label, uncontro...

Speaker: Georg Ebersbach, Institution: Movement Disorders Clinic, Event: VJVirtual, Event: EAN 2020, Subject: Parkinson's Disease, Subject: Movement Disorders, Field: Treatment, Field: Trial Updates, Medicines: Levodopa, Medicines: Opicapone, Trial: OPTIPARK, NCT02847442, Format: Interview
#############################